INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Concordia International Corp. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 31, 2016 / Lundin Law PC (the “Firm”) announces a class action lawsuit has been filed against Concordia International Corp. (“Concordia” or the “Company”) (Nasdaq: CXRX) concerning possible violations of federal securities laws between November 12, 2015 and August 12, 2016 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the October 14, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that during the Class Period, the Company made false and misleading statements and/or failed to disclose: that Concordia was facing increased market competition against its drug Donnatal and other products; that the Company’s financial results would suffer and thus it would be forced to suspend its dividend; and that as a result of the above, Concordia’s statements about its business, operations and prospects were false and misleading and/or lacked a reasonable basis.

On August 12, 2016, Concordia announced that it would lower its 2016 guidance due to unexpected competition and current foreign exchange rates. The Company also announced that CFO Adrian de Saldanha was leaving, and that the Board unanimously agreed to suspend the Company’s quarterly dividend. When this news was released to the public, shares of Concordia dropped in value, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 444605